Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04786106 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Investigation of Surgery, Collagenase, and Restorex for the Improvement of Peyronie's

Study acronym: iSCRIP
StatusActive, Not Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. 3 versions Re-verified since Sep 11, 2023, no change to tracked fieldsv3-v5
  2. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to compare key clinical outcomes of collagenase clostridium histolyticum injections versus surgery for the management of Peyronie's Disease.
Trial Details
NCT Number NCT04786106
Lead Sponsor Charitable Union for the Research and Education of Peyronie's Disease
Collaborators: Endo USA Inc., a Keenova Therapeutics Company
Conditions
(from sponsor)		 Peyronie's Disease
Related terms Penile Induration, Surgical Wound
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov